Medicis (MRX) Receives FDA Approval of DYSPORT(TM) for Therapeutic and Aesthetic Uses
Tweet Send to a Friend
Medicis (NYSE: MRX) and Ipsen today announced the U.S. FDA approval of the Biologics License Application for DYSPORT(TM) (abobotulinumtoxinA), an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
